NeoGenomics Inc. (NEO) Financial Statements (2025 and earlier)

Company Profile

Business Address 9490 NEOGENOMICS WAY
FORT MYERS, FL 33912
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 8734 - Testing Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments355,085331,914342,488306,239289,074275,609
Cash and cash equivalents355,085331,914342,488306,239289,074275,609
Receivables146,581140,279131,227132,640125,425118,842
Inventory, net of allowances, customer advances and progress billings23,21420,32024,15624,05324,94524,432
Inventory23,21420,32024,15624,05324,94524,432
Prepaid expense17,39619,15517,98718,67616,57116,185
Capitalized contract cost711     
Other current assets9,1579,3128,2399,3178,4337,622
Other undisclosed current assets32,05952,91672,71596,025120,272142,306
Total current assets:584,203573,896596,812586,950584,720584,996
Noncurrent Assets
Operating lease, right-of-use asset83,67186,57891,76987,13191,41293,784
Property, plant and equipment92,15887,86592,01294,517100,110102,845
Intangible assets, net (including goodwill)879,170887,530895,894904,676913,459922,243
Goodwill522,766522,766522,766522,766522,766522,766
Intangible assets, net (excluding goodwill)356,404364,764373,128381,910390,693399,477
Other noncurrent assets4,0754,4704,7424,9675,4075,306
Total noncurrent assets:1,059,0741,066,4431,084,4171,091,2911,110,3881,124,178
TOTAL ASSETS:1,643,2771,640,3391,681,2291,678,2411,695,1081,709,174
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities68,06652,94573,49564,41363,59955,603
Accounts payable17,18618,33620,33416,81917,91322,712
Accrued liabilities50,88034,60953,16147,59445,68632,891
Deferred revenue9721,1442,1303,6175,7126,067
Debt200,073  41138
Restructuring reserve    3,7714,1354,008
Other undisclosed current liabilities20,84822,62120,67921,12121,39120,890
Total current liabilities:289,95976,71096,30492,92694,84886,606
Noncurrent Liabilities
Long-term debt and lease obligation339,577538,923538,198537,475536,755536,037
Long-term debt, excluding current maturities339,577538,923538,198537,475536,755536,037
Liabilities, other than long-term debt97,857101,296105,190100,412107,313112,069
Deferred income tax liabilities23,01523,49024,28525,37028,81131,715
Other liabilities11,54813,03313,03413,03513,03413,035
Operating lease, liability63,29464,77367,87162,00765,46867,319
Total noncurrent liabilities:437,434640,219643,388637,887644,068648,106
Total liabilities:727,393716,929739,692730,813738,916734,712
Equity
Equity, attributable to parent, including:915,884923,410941,537947,428956,192974,462
Additional paid in capital1,209,5361,198,7291,190,1391,181,8761,172,8501,167,051
Accumulated other comprehensive loss(1,022)(1,330)(1,674)(1,846)(2,572)(2,834)
Accumulated deficit(292,758)(274,116)(247,055)(232,729)(214,213)(189,882)
Other undisclosed equity, attributable to parent128127127127127127
Total equity:915,884923,410941,537947,428956,192974,462
TOTAL LIABILITIES AND EQUITY:1,643,2771,640,3391,681,2291,678,2411,695,1081,709,174

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues164,502156,240155,552151,954146,917137,220
Cost of revenue
(Cost of Goods and Services Sold)
(92,008)(90,771)(87,964)(89,643)(87,026)(82,406)
Gross profit:72,49465,46967,58862,31159,89154,814
Operating expenses(94,435)(96,036)(86,162)(86,506)(89,785)(89,887)
Operating loss:(21,941)(30,567)(18,574)(24,195)(29,894)(35,073)
Nonoperating income (expense)4,590(263)124(96)730(114)
Investment income, nonoperating4,592     
Other nonoperating income (expense)(2)(263)124(96)730(114)
Interest and debt expense(1,666)(1,685)(13,738)2,8402,524 
Loss from continuing operations before equity method investments, income taxes:(19,017)(32,515)(32,188)(21,451)(26,640)(35,187)
Other undisclosed income from continuing operations before income taxes  4,83416,902  1,467
Loss from continuing operations before income taxes:(19,017)(27,681)(15,286)(21,451)(26,640)(33,720)
Income tax benefit3756209602,9352,3092,925
Net loss available to common stockholders, diluted:(18,642)(27,061)(14,326)(18,516)(24,331)(30,795)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(18,642)(27,061)(14,326)(18,516)(24,331)(30,795)
Comprehensive loss:(18,642)(27,061)(14,326)(18,516)(24,331)(30,795)
Other undisclosed comprehensive income, net of tax, attributable to parent3083441727262621,065
Comprehensive loss, net of tax, attributable to parent:(18,334)(26,717)(14,154)(17,790)(24,069)(29,730)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: